The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.

Inclusion of biospecimens in population-based studies is an integral part of understanding disease etiology, identifying biomarkers and developing prevention and treatment strategies. The Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial collected, processed and stored biospecimens from participants to create a biorepository of specimens which serves as a useful resource for a broad research community. PLCO collected blood samples from consented screening arm participants at six screening rounds and a buccal sample from consented control arm participants. In addition, formalin-fixed paraffin embedded tumor tissue specimens were collected for participants in both arms for selected cancer sites. Collection of biospecimens at multiple timepoints (i.e. serial samples) and prior to cancer diagnosis, paired with rich epidemiologic and screening data, makes the PLCO collection of biospecimens a uniquely valuable resource. As such, access to the PLCO biorepository is granted to investigators by a rigorous scientific review process and guided by a steering committee which is responsible for developing and implementing the biospecimen use policies. Here, we describe the procedures for biospecimen collection, processing, storage, requisition, and distribution, as well as data management employed in PLCO. We also provide examples of how the biospecimens have been used to advance cancer research and describe relevant lessons learned to help inform cohorts wishing to add or modify biospecimen collection.

[1]  Stacey A. Kenfield,et al.  Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom‐related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial , 2016, BJU International.

[2]  P. Hartge,et al.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. , 2014, Gynecologic oncology.

[3]  N. Rothman,et al.  Pooled Analysis of Mitochondrial DNA Copy Number and Lung Cancer Risk in Three Prospective Studies , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Peter Kraft,et al.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer , 2014, Nature Genetics.

[5]  Paolo Vineis,et al.  Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.

[6]  E. Gillanders,et al.  The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio. , 2014, Biopreservation and biobanking.

[7]  N. Rothman,et al.  Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. , 2014, Cancer research.

[8]  John D Potter,et al.  Estimating the heritability of colorectal cancer. , 2014, Human molecular genetics.

[9]  Joshua N Sampson,et al.  Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. , 2014, The American journal of clinical nutrition.

[10]  S. Chanock,et al.  Genome-wide association study of circulating vitamin D-binding protein. , 2014, The American journal of clinical nutrition.

[11]  Julie Goodman,et al.  Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer , 2014, International journal of cancer.

[12]  D. Silverman,et al.  LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants , 2014, Epigenetics.

[13]  R. Pfeiffer,et al.  Circulating inflammation markers and prospective risk for lung cancer. , 2013, Journal of the National Cancer Institute.

[14]  J. Gohagan,et al.  The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. , 2013, Journal of the National Cancer Institute.

[15]  C. Friedenreich,et al.  Genome-wide association study of endometrial cancer in E2C2 , 2013, Human Genetics.

[16]  N. Rothman,et al.  A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. , 2013, Blood.

[17]  Paolo Vineis,et al.  Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.

[18]  S. Chanock,et al.  Genome-Wide Association Study of Serum Selenium Concentrations , 2013, Nutrients.

[19]  Christian Gieger,et al.  Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture , 2013, Nature Genetics.

[20]  Jane E. Carpenter,et al.  A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. , 2012, Human molecular genetics.

[21]  Jianxin Shi,et al.  Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk , 2012, Cancer.

[22]  R. Hayes,et al.  Prospective Study of Genomic Hypomethylation of Leukocyte DNA and Colorectal Cancer Risk , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[23]  A. Baccarelli,et al.  A Case-Control Study of Peripheral Blood Mitochondrial DNA Copy Number and Risk of Renal Cell Carcinoma , 2012, PloS one.

[24]  Melissa Bondy,et al.  Genome-wide association study of glioma and meta-analysis , 2012, Human Genetics.

[25]  C. Carlson,et al.  Meta-analysis of new genome-wide association studies of colorectal cancer risk , 2011, Human Genetics.

[26]  Peter Kraft,et al.  Evaluation of polygenic risk scores for predicting breast and prostate cancer risk , 2011, Genetic epidemiology.

[27]  Peter Kraft,et al.  Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. , 2011, Journal of the National Cancer Institute.

[28]  S. Chanock,et al.  Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2011, PloS one.

[29]  R. Sinha,et al.  Iron Homeostasis and Distal Colorectal Adenoma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2011, Cancer Prevention Research.

[30]  J. Witte,et al.  Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer. , 2011, Omics : a journal of integrative biology.

[31]  D. Chasman,et al.  Genome-Wide Association Study of Relative Telomere Length , 2011, PloS one.

[32]  E. Rimm,et al.  Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption , 2011, PLoS genetics.

[33]  Sudhir Srivastava,et al.  A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer , 2011, Cancer Prevention Research.

[34]  R. Sinha,et al.  A Prospective Evaluation of C-reactive Protein Levels and Colorectal Adenoma Development , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[35]  I. M. Jones,et al.  Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2010, Carcinogenesis.

[36]  Paolo Vineis,et al.  Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 , 2011, Nature Genetics.

[37]  M. Thun,et al.  Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. , 2010, Human molecular genetics.

[38]  William Wheeler,et al.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.

[39]  M. Haznadar,et al.  Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk. , 2010, International journal of molecular epidemiology and genetics.

[40]  C. McCarty,et al.  Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[42]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[43]  Neil E Caporaso,et al.  B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.

[44]  Ying Wang,et al.  A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. , 2009, American journal of human genetics.

[45]  Heather A. Halvensleben,et al.  A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33 , 2009, Human Genetics.

[46]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[47]  R. Hayes,et al.  The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer , 2009, Aging cell.

[48]  R. Sinha,et al.  Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. , 2009, Cancer research.

[49]  William Wheeler,et al.  Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors , 2009, PloS one.

[50]  R. Hayes,et al.  Sexually Transmissible Infections and Prostate Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[51]  Karin M. Fredrikson,et al.  Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers , 2008, Human Genetics.

[52]  Nilanjan Chatterjee,et al.  Serum vitamin D concentration and prostate cancer risk: a nested case-control study. , 2008, Journal of the National Cancer Institute.

[53]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[54]  R. Hayes,et al.  Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. , 2007, Cancer research.

[55]  R. Hayes,et al.  Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. , 2006, Cancer research.

[56]  Nilanjan Chatterjee,et al.  Nucleotide Excision Repair Gene Polymorphisms and Risk of Advanced Colorectal Adenoma: XPC Polymorphisms Modify Smoking-Related Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[57]  Robert N Hoover,et al.  Methods for etiologic and early marker investigations in the PLCO trial. , 2005, Mutation research.

[58]  R. Hayes,et al.  GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[59]  R. Hayes,et al.  Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[60]  R. Hayes,et al.  Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[61]  R. Hayes,et al.  Whole blood cryopreservation in epidemiological studies. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[62]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[63]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.